Interestingly, STAT3 inhibition failed to prevent leukemia progression in immunodeficient mice, demonstrating that the anti-leukemia effects of STAT3 inhibition were likely immune-dependent [132, 133]. The gene discussed is STAT3; the disease is leukemia.